Lu Yao

6PUBLICATIONS
10CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Innate immunityPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 24, 2026
Reclassification of BRCA2 Variants of Uncertain Significance Using Saturation Genome Editing Combined with Clinical Phenotypes in Breast Cancer.

|Nov 06, 2025
Single-Cell Immune Signature and Response to Neoadjuvant Chemotherapy in BRCA1/2-Mutated Breast Cancer.

Li Hu, Linxi Chen, Yaxin Zhang

|Mar 26, 2025
Clinical Impact and Genomic Features of Human Epidermal Growth Factor Receptor 2-Low Tumors in BRCA1/2-Mutated Triple-Negative Breast Cancer.

Furong Kou, Huimin Liu, Yaxin Zhang

|Feb 07, 2023
Signal-induced enhancer activation requires Ku70 to read topoisomerase1-DNA covalent complexes.

Yuliang Tan, Lu Yao, Amir Gamliel

|Aug 16, 2022
Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype.

Fan Zang, Xinyun Ding, Jiuan Chen

|Apr 22, 2022
Clinical relevance of pathogenic germline variants in mismatch repair genes in Chinese breast cancer patients.

Li Hu, Jie Sun, Zhongwu Li

Pageof 1

Frequent Collaborators

5 joint publications

Yuntao Xie

3 joint publications

Jie Sun

2 joint publications

Huimin Liu

2 joint publications

Ye Xu